Loading organizations...
Key people at GrowingStronger.org non-profit.
GrowingStronger.org non-profit was founded in 2011 by Amer Haider (Parent, Founder).
GrowingStronger.org operates as a non-profit organization focused on advancing the medical care landscape for individuals living with dwarfism. The organization primarily supports research initiatives and develops crucial resources aimed at improving the quality of life and treatment options, particularly for those affected by achondroplasia. Its core capabilities revolve around fostering scientific inquiry and providing accessible information to the community it serves.
The non-profit was co-founded by Amer and Munira Haider, parents whose personal experiences likely illuminated the urgent need for enhanced medical support and understanding within the achondroplasia community. Their insight into the gaps in existing care pathways propelled the establishment of an organization committed to systemic improvement through dedicated research and resource creation.
The organization’s primary beneficiaries are individuals and families navigating life with achondroplasia. GrowingStronger.org envisions a future where comprehensive and effective medical care is readily available, driven by ongoing research and informed resources that empower the community and lead to better health outcomes.
Key people at GrowingStronger.org non-profit.
GrowingStronger.org non-profit was founded in 2011 by Amer Haider (Parent, Founder).
Growing Stronger is a 501(c)(3) nonprofit organization dedicated to supporting medical research and developing resources for individuals with achondroplasia, the most common form of dwarfism.[1][2][7] Founded by parents Amer and Munira Haider, it serves parents, caregivers, and the achondroplasia community—nearly 1,500 members worldwide—by providing education on medical care, treatment options, emotional support groups, and tools like "Achonversations" with experts.[1][2] The organization addresses gaps in care through science-driven empowerment, data collection partnerships (e.g., with RARE-X), and community-building, excluding physicians, researchers, and pharma affiliates to maintain a safe parent-focused space.[2][3]
It solves critical problems like isolation, limited access to pharmaceutical research info, and slow rare disease R&D by accelerating data for clinical trials, enabling placebo data use, and speeding treatments to patients—all at no cost to participants.[3]
Growing Stronger was co-founded by Amer and Munira Haider, parents motivated by their son Ahmin's 2008 birth with achondroplasia.[1] With three children—Meher (oldest daughter), Ahmin, and younger son Belal—the family turned personal challenges into action, aiming to improve medical care quality through research, health empowerment, and education.[1] Since Ahmin's diagnosis, they've built a mission around providing the support they lacked early on, evolving from family advocacy to a global community with resources like annual reports and media presence.[1][2][4]
Key pivotal moments include launching a monitored membership community and partnering with RARE-X for data collection to fuel achondroplasia research.[2][3]
Growing Stronger rides the rare disease data-sharing trend, leveraging tech from partners like the Broad Institute (MIT/Harvard) and RARE-X to structure patient data for researchers, clinicians, and biopharma—mirroring large-scale genomic initiatives.[3] Timing aligns with rising focus on real-world evidence for rare conditions like achondroplasia, where traditional trials lag; their program informs progression tracking, trial recruitment, and placebo alternatives, cutting development time.[3]
Market forces favor it: growing biopharma interest in orphan drugs, patient advocacy demands for faster therapies, and no-cost tech platforms democratizing data. It influences the ecosystem by empowering communities to drive R&D, potentially setting models for other skeletal dysplasias.[3]
Growing Stronger is poised to expand its data program, deepen RARE-X ties, and grow membership amid advancing achondroplasia treatments like pharmaceuticals.[2][3] Trends in AI-driven rare disease analytics and global patient registries will amplify its impact, evolving it from support hub to key R&D enabler. As community data scales, expect broader influence on trials and policy, strengthening families like the Haiders' from the start.[1][3]
